Home › Funds › Nextech Invest Ltd. › ENGN
Nextech Invest Ltd. position in ENGN
ENGENE THERAPEUTICS INC · Health Care
Nextech Invest Ltd. reported holding 2,324,943 shares of ENGN (ENGENE THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$4.0M, representing 0.19% of its reported portfolio and ranking #15 among its reported holdings. Nextech Invest Ltd. has disclosed ENGN holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Nextech Invest Ltd.'s ENGN position evolved
Nextech Invest Ltd. first disclosed a stake in ENGN in Q4 2025 at 2,124,943 shares (US$19.2M). Across 3 filings, Nextech Invest Ltd. increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 2,324,943 shares valued at US$4.0M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 2.12M | $19.19M | New |
| Q1 2026 | 2.32M | $15.83M | Add |
| Q2 2026 | 2.32M | $4.02M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ENGN and 13F data
ENGN (ENGENE THERAPEUTICS INC) is a Health Care company. 32 other funds we track also report a position in ENGN — the largest reported positions include FCPM III SERVICES B.V. (US$16.7M), BML Capital Management, LLC (US$11.5M), ACORN CAPITAL ADVISORS, LLC (US$2.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ENGN
- FCPM III SERVICES B.V. 9.63M sh · $16.66M · Q2 2026
- BML Capital Management, LLC 6.67M sh · $11.54M · Q2 2026
- ACORN CAPITAL ADVISORS, LLC 1.27M sh · $2.20M · Q2 2026
- Peapod Lane Capital LLC 1.04M sh · $2.08M · Q3 2026
- Omega Fund Management, LLC 876.36K sh · $1.52M · Q2 2026
- SR ONE CAPITAL MANAGEMENT, LP 747.75K sh · $1.29M · Q2 2026
- Kynam Capital Management, LP 457.86K sh · $792.09K · Q2 2026
- Elmind Capital, LP 210.00K sh · $363.30K · Q2 2026
More on Nextech Invest Ltd.
FAQ
How long has Nextech Invest Ltd. held ENGN?
Nextech Invest Ltd. has disclosed ENGN holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is Nextech Invest Ltd.'s current position in ENGN?
As of Q2 2026, Nextech Invest Ltd. holds 2.32M shares of ENGN (ENGENE THERAPEUTICS INC), valued at $4.02M, representing 0.19% of its reported portfolio and ranking #15.
Has Nextech Invest Ltd. been buying or selling ENGN?
In the latest 13F filing (Q2 2026), Nextech Invest Ltd. held unchanged its position in ENGN.
Which other funds hold ENGN?
Other major institutional holders of ENGN include FCPM III SERVICES B.V., BML Capital Management, LLC, ACORN CAPITAL ADVISORS, LLC, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.